The Ensign Group, Inc. (ENSG)
USD 132.32
(3.29%)
USD 132.32
(3.29%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 209.39 Million USD | -6.8% |
| 2022 | 224.68 Million USD | 15.43% |
| 2021 | 194.65 Million USD | 14.18% |
| 2020 | 170.47 Million USD | 54.23% |
| 2019 | 110.53 Million USD | 19.67% |
| 2018 | 92.36 Million USD | 128.2% |
| 2017 | 40.47 Million USD | -19.03% |
| 2016 | 49.99 Million USD | -9.82% |
| 2015 | 55.43 Million USD | 54.19% |
| 2014 | 35.95 Million USD | 49.54% |
| 2013 | 24.04 Million USD | -40.78% |
| 2012 | 40.59 Million USD | -14.86% |
| 2011 | 47.67 Million USD | 17.64% |
| 2010 | 40.52 Million USD | 24.75% |
| 2009 | 32.48 Million USD | 18.09% |
| 2008 | 27.5 Million USD | 34.01% |
| 2007 | 20.52 Million USD | -8.97% |
| 2006 | 22.54 Million USD | 22.63% |
| 2005 | 18.38 Million USD | 65.61% |
| 2004 | 11.1 Million USD | 70.87% |
| 2003 | 6.49 Million USD | 82.32% |
| 2002 | 3.56 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 71 Million USD | 3.16% |
| 2024 Q1 | 68.83 Million USD | 217.34% |
| 2024 Q3 | 78.44 Million USD | 10.47% |
| 2023 Q1 | 59.85 Million USD | -1.02% |
| 2023 Q3 | 63.86 Million USD | -0.2% |
| 2023 Q4 | 21.69 Million USD | -66.04% |
| 2023 Q2 | 63.99 Million USD | 6.92% |
| 2023 FY | 209.39 Million USD | -6.8% |
| 2022 Q1 | 50.34 Million USD | 3.28% |
| 2022 Q4 | 60.47 Million USD | 7.64% |
| 2022 FY | 224.68 Million USD | 15.43% |
| 2022 Q3 | 56.17 Million USD | -2.62% |
| 2022 Q2 | 57.69 Million USD | 14.6% |
| 2021 Q4 | 48.74 Million USD | 3.09% |
| 2021 FY | 194.65 Million USD | 14.18% |
| 2021 Q1 | 49.2 Million USD | 6.23% |
| 2021 Q2 | 49.42 Million USD | 0.45% |
| 2021 Q3 | 47.28 Million USD | -4.34% |
| 2020 FY | 170.47 Million USD | 54.23% |
| 2020 Q1 | 40.84 Million USD | 49.12% |
| 2020 Q4 | 46.32 Million USD | 7.57% |
| 2020 Q3 | 43.06 Million USD | 6.99% |
| 2020 Q2 | 40.24 Million USD | -1.47% |
| 2019 Q3 | 27.15 Million USD | -5.07% |
| 2019 Q4 | 27.39 Million USD | 0.87% |
| 2019 FY | 110.53 Million USD | 19.67% |
| 2019 Q1 | 27.37 Million USD | 3.84% |
| 2019 Q2 | 28.6 Million USD | 4.52% |
| 2018 FY | 92.36 Million USD | 128.2% |
| 2018 Q3 | 20.86 Million USD | -5.22% |
| 2018 Q2 | 22.01 Million USD | -4.85% |
| 2018 Q4 | 26.36 Million USD | 26.36% |
| 2018 Q1 | 23.13 Million USD | 106.43% |
| 2017 Q4 | 11.2 Million USD | -21.15% |
| 2017 FY | 40.47 Million USD | -19.03% |
| 2017 Q3 | 14.21 Million USD | 16.33% |
| 2017 Q1 | 2.84 Million USD | -84.51% |
| 2017 Q2 | 12.21 Million USD | 330.18% |
| 2016 Q2 | 11.32 Million USD | 23.48% |
| 2016 Q1 | 9.17 Million USD | -32.56% |
| 2016 Q3 | 11.15 Million USD | -1.51% |
| 2016 FY | 49.99 Million USD | -9.82% |
| 2016 Q4 | 18.33 Million USD | 64.38% |
| 2015 FY | 55.43 Million USD | 54.19% |
| 2015 Q3 | 13.47 Million USD | 2.15% |
| 2015 Q2 | 13.18 Million USD | -13.07% |
| 2015 Q1 | 15.17 Million USD | 31.79% |
| 2015 Q4 | 13.6 Million USD | 0.96% |
| 2014 Q4 | 11.51 Million USD | 29.25% |
| 2014 Q1 | 13.52 Million USD | 1.27% |
| 2014 Q2 | 2 Million USD | -85.16% |
| 2014 FY | 35.95 Million USD | 49.54% |
| 2014 Q3 | 8.9 Million USD | 343.75% |
| 2013 Q3 | 10.46 Million USD | -15.39% |
| 2013 Q2 | 12.36 Million USD | 201.81% |
| 2013 FY | 24.04 Million USD | -40.78% |
| 2013 Q4 | 13.35 Million USD | 27.64% |
| 2013 Q1 | -12.14 Million USD | -727.1% |
| 2012 FY | 40.59 Million USD | -14.86% |
| 2012 Q1 | 12.9 Million USD | 24.62% |
| 2012 Q2 | 12.45 Million USD | -3.47% |
| 2012 Q3 | 13.29 Million USD | 6.73% |
| 2012 Q4 | 1.93 Million USD | -85.43% |
| 2011 Q1 | 12.74 Million USD | 9.2% |
| 2011 Q2 | 12.97 Million USD | 1.8% |
| 2011 Q4 | 10.35 Million USD | -10.72% |
| 2011 FY | 47.67 Million USD | 17.64% |
| 2011 Q3 | 11.59 Million USD | -10.62% |
| 2010 Q1 | 9.34 Million USD | 7.53% |
| 2010 Q4 | 11.67 Million USD | 18.05% |
| 2010 FY | 40.52 Million USD | 24.75% |
| 2010 Q3 | 9.88 Million USD | 2.79% |
| 2010 Q2 | 9.61 Million USD | 2.9% |
| 2009 Q2 | 8.18 Million USD | 3.29% |
| 2009 Q1 | 7.92 Million USD | 0.81% |
| 2009 Q3 | 7.68 Million USD | -6.09% |
| 2009 Q4 | 8.69 Million USD | 13.1% |
| 2009 FY | 32.48 Million USD | 18.09% |
| 2008 Q1 | 6.33 Million USD | 1.69% |
| 2008 Q4 | 7.85 Million USD | 15.62% |
| 2008 Q3 | 6.79 Million USD | 4.26% |
| 2008 Q2 | 6.51 Million USD | 2.92% |
| 2008 FY | 27.5 Million USD | 34.01% |
| 2007 Q4 | 6.22 Million USD | 39.48% |
| 2007 Q3 | 4.46 Million USD | -21.58% |
| 2007 Q1 | 4.13 Million USD | -26.61% |
| 2007 FY | 20.52 Million USD | -8.97% |
| 2007 Q2 | 5.69 Million USD | 37.66% |
| 2006 Q1 | 5.63 Million USD | 22.62% |
| 2006 Q2 | 5.63 Million USD | 0.0% |
| 2006 Q3 | 5.63 Million USD | 0.0% |
| 2006 FY | 22.54 Million USD | 22.63% |
| 2006 Q4 | 5.63 Million USD | 0.0% |
| 2005 FY | 18.38 Million USD | 65.61% |
| 2005 Q3 | 4.59 Million USD | 0.0% |
| 2005 Q4 | 4.59 Million USD | 0.0% |
| 2005 Q2 | 4.59 Million USD | 0.0% |
| 2005 Q1 | 4.59 Million USD | 0.0% |
| 2004 FY | 11.1 Million USD | 70.87% |
| 2003 FY | 6.49 Million USD | 82.32% |
| 2002 FY | 3.56 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | -21.66 Million USD | 1066.442% |
| Addus HomeCare Corporation | 62.51 Million USD | -234.953% |
| AirSculpt Technologies, Inc. | -4.47 Million USD | 4775.128% |
| Amedisys, Inc. | -9.74 Million USD | 2248.343% |
| Astrana Health, Inc. | 60.71 Million USD | -244.877% |
| Aveanna Healthcare Holdings Inc. | -134.52 Million USD | 255.659% |
| IMAC Holdings, Inc. | - USD | -Infinity% |
| biote Corp. | 3.31 Million USD | -6214.807% |
| Cryo-Cell International, Inc. | -9.52 Million USD | 2299.184% |
| Cross Country Healthcare, Inc. | 72.63 Million USD | -188.305% |
| COMPASS Pathways plc | -118.46 Million USD | 276.762% |
| DocGo Inc. | 6.85 Million USD | -2953.151% |
| Healthcare Services Group, Inc. | 38.38 Million USD | -445.509% |
| InnovAge Holding Corp. | -21.33 Million USD | 1081.343% |
| The Joint Corp. | -9.75 Million USD | 2247.198% |
| LifeStance Health Group, Inc. | -186.26 Million USD | 212.422% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.6 Million USD | 1442.061% |
| ModivCare Inc. | -204.46 Million USD | 202.416% |
| NewGenIvf Group Limited | 130.19 Thousand USD | -160737.372% |
| Option Care Health, Inc. | 267.09 Million USD | 21.6% |
| P3 Health Partners Inc. | -57.77 Million USD | 462.451% |
| P3 Health Partners Inc. | -57.77 Million USD | 462.451% |
| The Pennant Group, Inc. | 13.37 Million USD | -1465.132% |
| Surgery Partners, Inc. | -11.9 Million USD | 1859.655% |
| Syra Health Corp. Class A Common Stock | -2.93 Million USD | 7226.431% |
| Talkspace, Inc. | -19.18 Million USD | 1191.643% |
| Talkspace, Inc. | -19.18 Million USD | 1191.643% |
| The Oncology Institute, Inc. | -83.06 Million USD | 352.081% |
| The Oncology Institute, Inc. | -83.06 Million USD | 352.081% |